TrialBritish journal of haematology2017

Romiplostim monotherapy in thrombocytopenic patients with myelodysplastic syndromes: long-term safety and efficacy.

Pierre Fenaux et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.